Biotech council's direction dismays some members
5889
As the Massachusetts Biotechnology Council's new leader faces ethics questions, some members say they have become disenchanted with the trade group, including its increasing focus on lobbying, a high staff turnover rate, and the low number of top executives serving on its board.
539587
On the sidelines of a seminar in Jakarta last week, Marina Mahathir, President of the Malaysian AIDS Council talked to The Jakarta Post&#39;s M. Taufiqurrahman last week about how reluctance to address the issue of multiculturism had aggravated the problems
460653
The Massachusetts Biotechnology Council's recent track record on Beacon Hill is the envy of most other industry lobbies. On issues from blocking drug price-control efforts to state funding for job training, the council has successfully persuaded the Democrat-controlled Legislature and Republican Governor Mitt Romney to vote its way.
401065
U.S. oversight of genetically  modified crops, which critics charge is insufficient, may be  overhauled following a series of proposed changes released on  Thursday by the Agriculture Department.
549362
(Indianapolis-December 8, 2004) - As the City of Indianapolis tries to build an image as a center for the life sciences, one of its premiere biotechnology companies could be leaving.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
704946
Recently we have seen dis- cussions by the president and first lady and two op-ed pieces about stem cell research, one on Aug. 12 by Richard Cohen and one on Aug. 15 by Michael Kinsley. Only the column by Mr. Kinsley came anywhere close to presenting the ...
145474
Looking over all the biotech stock stories I covered in 2004, I&#39;m pleased to report that I was right more than wrong. My &quot;win&quot; column does veer in the bearish direction, which is not ideal (I&#39;d prefer more
667925
Angry members of Congress  took federal health officials to task yesterday for what they said was a pattern of being "soft" on government scientists found to have violated ethics rules.
591644
BASF's Amflora off the menu The European Union's Council of Ministers last week delivered a serious blow to biotech companies' ambitions to roll out GM crops across the region by postponing a decision on the "commercial optimisation" of BASF's Amflora "genetically optimised potato".â¦
374121
It's time to get down to business for stem-cell scientists and administrators after the tremendous boost they received from the passage of California's Proposition 71. Two advisory board appointments have been made; there are 25 to go. By Kristen Philipkoski.
407294
The biotech company announces new drug delays.
41829
The Food and Drug Administration of the US found itself in the midst of a rather unpleasant controversy. Recently the chief of Cleveland Clinic Foundationâs department of cardiovascular medicine blamed this
290464
Growers and scientists were beginning to grasp the difficulties officials face in trying to pinpoint the source of the bacteria.
267800
Last week's disclosure that former House Speaker Thomas Finneran will run the Massachusetts Biotechnology Council was just the latest sign that life sciences is a key industry in Boston.
124030
Almost one-fifth of the Food and Drug Administration scientists surveyed two years ago as part of an official review said they had been pressured to recommend approval of a new drug despite
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.